Dr. Choi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
676 N Saint Clair St
Ste 1600
Chicago, IL 60611Phone+1 312-695-0307Fax+1 312-695-0664
Summary
- Dr. Jennifer Choi is a dermatologist in Chicago, IL and is affiliated with multiple hospitals in the area, including Northwestern Memorial Hospital and Ann & Robert H. Lurie Children's Hospital of Chicago. She received her medical degree from Yale School of Medicine and has been in practice 14 years. She is experienced in chemotherapy, melanoma, and drug eruptions.
Education & Training
- Yale-New Haven Medical CenterResidency, Dermatology, 2004 - 2007
- Brigham and Women's HospitalInternship, Internal Medicine, 2003 - 2004
- Yale School of MedicineClass of 2003
Certifications & Licensure
- IL State Medical License 2015 - 2026
- CT State Medical License 2007 - 2016
- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow (FAAD) American Academy of Dermatology
Publications & Presentations
PubMed
- 165 citationsClinical and Histologic Features of Lichenoid Mucocutaneous Eruptions Due to Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 Immunotherapy.Veronica J. Shi, Nemanja Rodić, Scott N. Gettinger, Jonathan S. Leventhal, Julia Pettersen Neckman
JAMA Dermatology. 2016-10-01 - 87 citationsSebaceous carcinoma: evidence-based clinical practice guidelinesJoshua L. Owen, Nour Kibbi, Brandon Worley, Ryan C. Kelm, Jordan V Wang
The Lancet. Oncology. 2019-12-01 - 12 citationsThe Role of Personal Accomplishment in General Surgery Resident Well-being.Rhami Khorfan, Yue Yung Hu, Gaurava Agarwal, Joshua Eng, Taylor S. Riall
Annals of Surgery. 2021-01-22
Press Mentions
- Current Evidence for Safety and Efficacy of Anti-PD-1 Agents in the Treatment of Cutaneous Squamous Cell Carcinoma: A Systematic ReviewSeptember 26th, 2019
- Northwestern Dermatology FacultyDecember 24th, 2020
- No OS Benefit for Adjuvant Treatment of Stage III MelanomaJune 17th, 2023
Professional Memberships
- Fellow
- Medical Dermatology SocietyMember
- Women's Dermatologic SocietyMember
Industry Relationships
- Advisory Board Member, Biotest AG
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: